StockNews.com began coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research note released on Saturday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Trading Up 1.0 % NASDAQ ABIO opened at $2.04 on Friday. The firm has a market capitalization of $29.40 million, a P/E ratio […]